MedPath

MEGA FINPLEX

Registration Number: MAL15055017NC

Approved
Approval ID

4f29755776e7b3ad

Registration Number

MAL15055017NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

30capsule CapsulesAvailable
Package Size: 30capsule Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (11)

COENZYME Q10 (UBIDECARENONE)Active
Monograph: coenzyme q 10 (ubidecarenone)
VACCINIUM MYRTILLUS FRUIT EXTRACT (BILBERRY)Active
Monograph: vaccinium myrtillus fruit extract (bilberry)
ALPHA LIPOIC ACIDActive
Monograph: 硫辛酸
GLYCINE MAXActive
Monograph: glycine max
RICE EXTRACT (ORYZA SATIVA)Active
Monograph: rice extract (oryza sativa)
FLAX SEED OIL (LINUM USITATISSIMUM)Active
Monograph: flax seed oil (linum usitatissimum)
ASCORBYL PALMITATEActive
Monograph: ascorbyl palmitate
PROTEIN-MARINEActive
Monograph: protein-marine
TOCOPHERYL ACETATE, D-ALPHAActive
Monograph: tocopheryl acetate, d-alpha
EVENING PRIMROSE OIL (OENOTHERA BIENNIS)Active
Monograph: evening primrose oil (oenothera biennis)
VITIS VINIFERA (GRAPE SEED EXTRACT)Active
Monograph: vitis vinifera (grape seed extract)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEGA FINPLEX - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform